• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hypothalamic-pituitary-adrenocortical function in geriatric depression: diagnostic and treatment implications.

作者信息

Georgotas A, Stokes P E, Krakowski M, Fanelli C, Cooper T

出版信息

Biol Psychiatry. 1984 May;19(5):685-93.

PMID:6733180
Abstract

Extensive work in the field has indicated a state-dependent hyperactivity of the hypothalamic-pituitary-adrenocortical (HYPAC) functions and unresponsiveness to dexamethasone suppression in at least 50% of patients suffering from endogenous depression. In this study, elderly outpatients, 60-85 years of age, suffering from major depressive illness according to research diagnostic criteria (RDC) were studied with the dexamethasone suppression test (DST). Careful diagnostic evaluation included RDC, the Newcastle index, and clinical interviews focusing on "endogenomorphic features." The great majority (83.3%) of patients diagnosed as endogenous depressives were nonsuppressors (abnormal DST) as compared to 16.7% nonsuppressors amongst nonendogenous patients. In addition, DST tended to normalize the clinical recovery. The research and clinical implications of our findings in this population are further discussed.

摘要

相似文献

1
Hypothalamic-pituitary-adrenocortical function in geriatric depression: diagnostic and treatment implications.
Biol Psychiatry. 1984 May;19(5):685-93.
2
Normalization of dexamethasone suppression test: a laboratory index of recovery from endogenous depression.
Biol Psychiatry. 1980 Jun;15(3):449-58.
3
[Influence of depressive history on biological parameters in major depression].[抑郁病史对重度抑郁症生物学参数的影响]
Encephale. 2002 Jan-Feb;28(1):51-8.
4
Depression and the dexamethasone suppression test (DST) in patients with non-specific somatic complaints. Atypical depression and DST.非特异性躯体主诉患者的抑郁与地塞米松抑制试验(DST)。非典型抑郁与DST。
Ann Clin Res. 1985;17(4):148-51.
5
Dexamethasone suppression test status does not predict differential response to nortriptyline versus amitriptyline.地塞米松抑制试验结果不能预测对去甲替林和阿米替林的不同反应。
J Clin Psychopharmacol. 1988 Dec;8(6):421-5.
6
Obsessive-compulsive disorder, depression, and the dexamethasone suppression test.强迫症、抑郁症与地塞米松抑制试验
J Clin Psychopharmacol. 1987 Jun;7(3):182-4.
7
Dexamethasone suppression in depressed elderly outpatients.
J Clin Psychiatry. 1984 Sep;45(9):397-8.
8
Use of biologic markers in a general hospital affective disorders program.生物标志物在综合医院情感障碍项目中的应用。
J Clin Psychiatry. 1985 Jun;46(6):217-21.
9
Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.抑郁症患者和对照组的血浆地塞米松浓度以及皮质醇和皮质酮的差异抑制反应。
Biol Psychiatry. 1984 Mar;19(3):281-91.
10
Dexamethasone suppression test and treatment response.
J Clin Psychiatry. 1984 Sep;45(9):387-9.